Therapeutic effects of adipose-derived stem cells pretreated with pioglitazone in an emphysema mouse model

Experimental and Molecular Medicine

Volumn 48, Issue 10, 2016, Pages

  Hong, Yoonki ^a   Kim, You Sun ^b   Hong, Seok Ho ^a   Oh, Yeon Mok ^c  

^a Kangwon National University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

^c Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 7; CIGARETTE SMOKE; ELASTASE; FIBROBLAST GROWTH FACTOR 2; PIOGLITAZONE; SCATTER FACTOR; VASCULOTROPIN; 2,4 THIAZOLIDINEDIONE DERIVATIVE; PANCREATIC ELASTASE;

ADIPOSE DERIVED STEM CELL; AIRWAY EPITHELIUM CELL; ALVEOLAR REGENERATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; EMPHYSEMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PIOGLITAZONE PRETREATED ADIPOSE DERIVED STEM CELL; PROTEIN SYNTHESIS; STEM CELL TRANSPLANTATION; TISSUE REGENERATION; ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; CELL LINE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; FEMALE; LUNG; LUNG EMPHYSEMA; PATHOLOGY; PROCEDURES; SMOKE; STEM CELL;

ADIPOSE TISSUE; ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; FEMALE; LUNG; MICE, INBRED C57BL; PANCREATIC ELASTASE; PULMONARY EMPHYSEMA; SMOKE; STEM CELL TRANSPLANTATION; STEM CELLS; THIAZOLIDINEDIONES;

EID: 85020513989     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/emm.2016.93     Document Type: Article

References (34)

1. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532–555.
2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765–773.
3. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004; 364: 709–721.
4. MacNee W, Tuder RM. New paradigms in the pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6: 527–531.
5. Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 2007; 87: 1047–1082.
6. Anjos-Afonso F, Siapati EK, Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. J Cell Sci 2004; 117: 5655–5664.
7. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008; 103: 1204–1219.
8. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430–436.
9. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001; 98: 10344–10349.
10. Horwitz EM, Prockop DJ, Fitzpatrick LA, Koo WW, Gordon PL, Neel M et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999; 5: 309–313.
11. Zhao DC, Lei JX, Chen R, Yu WH, Zhang XM, Li SN et al. Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats. World J Gastroenterol 2005; 11: 3431–3440.
12. Matthay MA, Goolaerts A, Howard JP, Lee JW. Mesenchymal stem cells for acute lung injury: preclinical evidence. Crit Care Med 2010; 38: S569–S573.
13. Longhini-Dos-Santos N, Barbosa-de-Oliveira VA, Kozma RH, Faria CA, Stessuk T, Frei F et al. Cell therapy with bone marrow mononuclear cells in elastase-induced pulmonary emphysema. Stem Cell Rev 2013; 9: 210–218.
14. Cruz FF, Antunes MA, Abreu SC, Fujisaki LC, Silva JD, Xisto DG et al. Protective effects of bone marrow mononuclear cell therapy on lung and heart in an elastase-induced emphysema model. Respir Physiol Neurobiol 2012; 182: 26–36.
15. Shigemura N, Okumura M, Mizuno S, Imanishi Y, Nakamura T, Sawa Y. Autologous transplantation of adipose tissue-derived stromal cells ameliorates pulmonary emphysema. Am J Transplant 2006; 6: 2592–2600.
16. Katsha AM, Ohkouchi S, Xin H, Kanehira M, Sun R, Nukiwa T et al. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther 2011; 19: 196–203.
17. Schweitzer KS, Johnstone BH, Garrison J, Rush NI, Cooper S, Traktuev DO et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med 2011; 183: 215–225.
18. Huh JW, Kim SY, Lee JH, Lee JS, Van Ta Q, Kim M et al. Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am J Physiol Lung Cell Mol Physiol 2011; 301: L255–L266.
19. Weiss DJ, Casaburi R, Flannery R, LeRoux-Williams M, Tashkin DP. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest 2013; 143: 1590–1598.
20. Murphy MB, Moncivais K, Caplan AI. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 2013; 45: e54.
21. Kim YS, Kim JY, Shin DM, Huh JW, Lee SW, Oh YM. Tracking intravenous adipose-derived mesenchymal stem cells in a model of elastase-induced emphysema. Tuberc Respir Dis (Seoul) 2014; 77: 116–123.
22. Kim YS, Kim JY, Huh JW, Lee SW, Choi SJ, Oh YM. The therapeutic effects of optimal dose of mesenchymal stem cells in a murine model of an elastase induced-emphysema. Tuberc Respir Dis (Seoul) 2015; 78: 239–245.
23. Shinmura D, Togashi I, Miyoshi S, Nishiyama N, Hida N, Tsuji H et al. Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function. Stem Cells 2011; 29: 357–366.
24. Haynesworth SE, Baber MA, Caplan AI. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexa-methasone and IL-1 alpha. J Cell Physiol 1996; 166: 585–592.
25. Hegab AE, Kubo H, Yamaya M, Asada M, He M, Fujino N et al. Intranasal HGF administration ameliorates the physiologic and morphologic changes in lung emphysema. Mol Ther 2008; 16: 1417–1426.
26. Muyal JP, Muyal V, Kotnala S, Kumar D, Bhardwaj H. Therapeutic potential of growth factors in pulmonary emphysematous condition. Lung 2013; 191: 147–163.
27. Guan XJ, Song L, Han FF, Cui ZL, Chen X, Guo XJ et al. Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors. J Cell Biochem 2013; 114: 323–335.
28. Kasahara Y, Tuder RM, Taraseviciene-Stewart L, Le Cras TD, Abman S, Hirth PK et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J Clin Invest 2000; 106: 1311–1319.
29. Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K et al. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem 2001; 276: 41245–41254.
30. Matsushita K, Wu Y, Okamoto Y, Pratt RE, Dzau VJ. Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 2006; 48: 1095–1102.
31. Werner C, Kamani CH, Gensch C, Böhm M, Laufs U. The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance. Diabetes 2007; 56: 2609–2615.
32. Vosough M, Moossavi S, Mardpour S, Akhlaghpoor S, Azimian V, Jarughi N et al. Repeated intraportal injection of mesenchymal stem cells in combination with pioglitazone in patients with compensated cirrhosis: a clinical report of two cases. Arch Iran Med 2016; 19: 131–136.
33. Wang L, Li L, Gao H, Li Y.. Effect of pioglitazone on transdifferentiation of preosteoblasts from rat bone mesenchymal stem cells into adipocytes. J Huazhong Univ Sci Technolog Med Sci 2012; 32: 530–533.
34. Hou J, Wang L, Hou J, Guo T, Xing Y, Zheng S et al. Peroxisome proliferator-activated receptor gamma promotes mesenchymal stem cells to express connexin43 via the inhibition of TGF-β1/smads signaling in a rat model of myocardial infarction. Stem Cell Rev 2015; 11: 885–899.